- Last updated
🌐 Spain/UK — Agreement for the marketing of Sativex in Europe
GW Pharmaceuticals and Almirall Prodesfarma announced on 12 December that they have entered into an exclusive agreement for Almirall to market Sativex in Europe (excluding the UK). Sativex is a cannabis extract produced by the British company GW Pharmaceuticals. Almirall is Spain’s largest pharmaceutical company and one of Europe’s leading private pharmaceutical companies. It is headquartered in Barcelona and is currently present in around 100 countries worldwide. It has subsidiary operations in several European markets, including France, Germany, Italy, Portugal and Belgium.